Utah Medical Products Profit Margin 2006-2020 | UTMD

Current and historical gross margin, operating margin and net profit margin for Utah Medical Products (UTMD) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Utah Medical Products net profit margin as of June 30, 2020 is 28.44%.
Utah Medical Products Annual Profit Margins
Utah Medical Products Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.285B $0.047B
Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $181.887B 34.13
Medtronic (MDT) Ireland $138.427B 26.07
Stryker (SYK) United States $75.865B 29.42
Boston Scientific (BSX) United States $53.965B 31.17
Lonza Group Ag (LZAGY) Switzerland $46.014B 0.00
Baxter (BAX) United States $39.653B 24.25
Terumo (TRUMY) Japan $30.123B 38.51
Zimmer Biomet Holdings (ZBH) United States $27.691B 22.98
EssilorLuxottica Societe Anonyme (ESLOY) France $26.945B 0.00
ResMed (RMD) United States $24.445B 35.44
Sunny Optical Technology (SNPTF) China $17.659B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $16.497B 0.00
Bio-Rad Laboratories (BIO) United States $15.189B 68.69
Insulet (PODD) United States $14.945B 632.36
Shandong Weigao Medical Polymer (SHWGF) China $11.080B 0.00
DiaSorin S.p.A (DSRLF) Italy $10.350B 0.00
GN STORE NORD (GNNDY) Denmark $10.221B 52.10
Quidel (QDEL) United States $8.231B 43.60
William Demant Holdings (WILYY) Denmark $7.100B 0.00
Perrigo (PRGO) Ireland $6.192B 10.63
Hill-Rom Holdings (HRC) United States $5.491B 13.63
Canopy Growth (CGC) Canada $5.428B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.362B 0.00
Haemonetics (HAE) United States $4.233B 28.21
Neogen (NEOG) United States $3.961B 64.96
ICU Medical (ICUI) United States $3.885B 29.64
Envista Holdings (NVST) United States $3.637B 24.80
TG Therapeutics (TGTX) United States $3.131B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.105B 0.00
Abcam (ABCZY) $3.102B 0.00
National Vision Holdings (EYE) United States $3.026B 470.38
NuVasive (NUVA) United States $2.513B 35.03
Agios Pharmaceuticals (AGIO) United States $2.442B 0.00
AtriCure (ATRC) United States $1.731B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.686B 153.85
NanoString Technologies (NSTG) United States $1.657B 0.00
Cardiovascular Systems (CSII) United States $1.417B 0.00
MacroGenics (MGNX) United States $1.338B 0.00
Aphria (APHA) Canada $1.282B 0.00
InMode (INMD) Israel $1.134B 28.60
Cerus (CERS) United States $0.979B 0.00
Quanterix (QTRX) United States $0.932B 0.00
Owens & Minor (OMI) United States $0.880B 19.70
BioLife Solutions (BLFS) United States $0.870B 453.00
PetIQ (PETQ) United States $0.853B 24.48
OraSure Technologies (OSUR) United States $0.831B 0.00
Lantheus Holdings (LNTH) United States $0.800B 11.09
Meridian Bioscience (VIVO) United States $0.715B 16.51
Phibro Animal Health (PAHC) United States $0.712B 16.30
LeMaitre Vascular (LMAT) United States $0.677B 41.30
Vapotherm (VAPO) United States $0.661B 0.00
Aurora Cannabis (ACB) Canada $0.597B 0.00
Zynex (ZYXI) United States $0.579B 50.58
Omeros (OMER) United States $0.558B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.538B 76.04
Surmodics (SRDX) United States $0.524B 57.52
VAREX IMAGING (VREX) United States $0.463B 20.07
Cytosorbents (CTSO) United States $0.336B 0.00
Viemed Healthcare (VMD) United States $0.325B 11.62
HEXO (HEXO) $0.323B 0.00
InfuSystems Holdings (INFU) United States $0.259B 49.35
Neptune Wellness Solutions (NEPT) Canada $0.243B 0.00
Surface Oncology (SURF) United States $0.241B 0.00
Organigram Holdings (OGI) Canada $0.216B 0.00
Chimerix (CMRX) United States $0.187B 0.00
Female Health (VERU) United States $0.187B 0.00
Wound Management Technologies (SMTI) United States $0.163B 0.00
Bovie Medical (APYX) United States $0.150B 0.00
Fonar (FONR) United States $0.144B 12.79
Exagen (XGN) United States $0.138B 0.00
Liberty Health Sciences (LHSIF) United States $0.133B 0.00
Evolus (EOLS) United States $0.126B 0.00
Capricor Therapeutics (CAPR) United States $0.101B 0.00
Chembio Diagnostics (CEMI) United States $0.088B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.087B 0.00
Rockwell Medical (RMTI) United States $0.084B 0.00
United-Guardian (UG) United States $0.068B 15.35
Oramed Pharmaceuticals (ORMP) United States $0.065B 0.00
Brainsway (BWAY) Israel $0.063B 0.00
MTech Acquisition (KERN) United States $0.054B 0.00
Nephros (NEPH) United States $0.053B 0.00
Trinity Biotech (TRIB) Ireland $0.049B 9.27
ImmuCell (ICCC) United States $0.038B 0.00
FSD PHARMA INC (HUGE) Canada $0.034B 0.00
GUARDION HEALTH (GHSI) United States $0.020B 0.00
Akers Biosciences Inc (AKER) United States $0.020B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.018B 0.00
NF Energy Saving (BIMI) China $0.017B 0.00
Myomo (MYO) United States $0.016B 0.00
NeuroMetrix (NURO) United States $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00